drugset / Trial / NCT03088254
Study to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine/Rosuvastatin
RandomizedParallel-groupTriple-blindTreatment
Summary
To evaluate efficacy and safety of co-administrated temisartan/amlodipine and rosuvastatin in subjects with dyslipidemia with hypertension.
Timeline
- Start
- 2016-09-20
- Primary completion
- 2017-07-31
- Completion
- 2017-12-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amlodipine | Other / unclassified | 10 mg | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |
| Subject | Telmisartan | Other / unclassified | 80 mg | — |
Indications
No indication recorded.